Scientific knowledge is scattered, siloed, and slow to search. Amass integrates across this fragmented landscape – patents, papers, regulatory filings, proprietary documents and internal data – and applies AI to create a structured, cross-linked, and queryable knowledge graph.
We proudly serve and collaborate with key players across the scientific ecosystem.
Link every internal file – SharePoint decks, OneDrive folders, instrument .csvs – with external goldmines like PubMed®, Lens patents and ClinicalTrials.gov. GEMA stitches them into a single, searchable workspace where each chat, note or report stays traceable to the source, version-controlled and access-safe. One fabric for discovery, ops and compliance – no tab-hopping required.
Amass is the AI-first platform built for modern science teams – from discovery to decision. Literature, data, insights, and strategy – unified.
Go beyond search—build understanding.
Instantly surface, cluster and summarise 40 million PubMed articles, 155 million patents and 200 million cross-disciplinary papers. Deep-Dive reports cut noise, highlight novel connections and export citations in any style. From first hypothesis to final figure, the latest science lands in your workflow—no VPNs, paywalls or endless keyword tweaking
Stay ahead, not reactive.
Track competitors, pipelines and market signals in real time. GEMA scans Lens patents, ClinicalTrials.gov, congress abstracts and news feeds, then distils trends into shareable dashboards. Spot white-space, assess freedom-to-operate and brief execs before the market moves—all without hiring an army of analysts.
Ask once. Get holistic answers.
Pose a single question—“Which Wnt-pathway inhibitors have Phase II results?”—and GEMA pulls from both your private datasets and global knowledge bases, delivering a citation-backed answer plus links to raw data. Follow-up queries stay in context, so insights deepen with each exchange instead of starting from scratch.
From PhD students and bench scientists to clinical ops, business strategists, and venture analysts, GEMA delivers the same research-grade AI wherever decisions are made.
Even in early access, Amass is built to meet the standards of the most demanding science teams.
Your internal notes, experiments, and documents are never used for model training. We believe scientific knowledge is your competitive advantage—not ours.
Whether you’re exploring a trial, need a custom quote, or just want to see GEMA in action, we’re here to help.